Tuberculosis-HIV treatment with rifampicin or rifabutin: are the outcomes different?

BACKGROUND Rifamycins are a group of antibiotics mainly used in the treatment of tuberculosis (TB), however they interact with antiretroviral therapy (ART). Rifabutin allows more regimens options for concomitant imunodeficiency virus (HIV) treatment compared to rifampicin. OBJECTIVE Compare the o...

Full description

Bibliographic Details
Main Authors: Carolina Arana Stanis Schmaltz, Fernanda de Oliveira Demitto, Flavia Marinho Sant’Anna, Valeria Cavalcanti Rolla
Format: Article
Language:English
Published: Fundação Oswaldo Cruz (FIOCRUZ) 2019-02-01
Series:Memorias do Instituto Oswaldo Cruz
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762019000100312&lng=en&tlng=en